Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

Jason K. Russell; Zinayida Schlachetzki; Beau M. Ances; Michael S. Rafii

doi:10.1001/jamaneurol.2025.5261

Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

Jason K. Russell
, Zinayida Schlachetzki
, Beau M. Ances
, Michael S. Rafii

Research output: Contribution to journal › Article › peer-review

Abstract

This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.

Original language	English
Journal	JAMA Neurology
DOIs	https://doi.org/10.1001/jamaneurol.2025.5261
State	Accepted/In press - 2026

Access to Document

10.1001/jamaneurol.2025.5261

Cite this

@article{a4f430fd9ff4424bb8726cfe5a62320d,

title = "Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome",

abstract = "This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.",

author = "Russell, \{Jason K.\} and Zinayida Schlachetzki and Ances, \{Beau M.\} and Rafii, \{Michael S.\}",

note = "Publisher Copyright: {\textcopyright} 2026 American Medical Association. All rights reserved, including those for text and data mining, AI training, and similar technologies. American Medical Association.",

year = "2026",

doi = "10.1001/jamaneurol.2025.5261",

language = "English",

journal = "JAMA Neurology",

issn = "2168-6149",

}

TY - JOUR

T1 - Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

AU - Russell, Jason K.

AU - Schlachetzki, Zinayida

AU - Ances, Beau M.

AU - Rafii, Michael S.

PY - 2026

Y1 - 2026

N2 - This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.

AB - This cross-sectional study examines data for participants in the Alzheimer Biomarker Consortium–Down Syndrome study to gauge the concordance of clinical and biological Alzheimer disease staging.

UR - https://www.scopus.com/pages/publications/105028191737

U2 - 10.1001/jamaneurol.2025.5261

DO - 10.1001/jamaneurol.2025.5261

M3 - Article

C2 - 41525055

AN - SCOPUS:105028191737

SN - 2168-6149

JO - JAMA Neurology

JF - JAMA Neurology

ER -

Concordance of Biological and Clinical Staging of Alzheimer Disease Pathology in Down Syndrome

Abstract

Access to Document

Other files and links

Fingerprint

Cite this